Main Profile

At A Glance

Unchanged Fiscal Policies Will Hollow Out Investments Made in Bioscience

Senator Michael Bennett (D-CO): Funding for biomedical innovation is tied to our fiscal policies, which we need to fix. As our debt grows, spending on new therapies declines, meanwhile the rest of the world is waiting for us to get our act together. On June 27, the Engelberg Center for Health Care Reform at Brookings hosted the State of Biomedical Innovation Conference in Washington, DC, with a keynote address and discussion with Senator Michael Bennett (D-CO). Designed to bring together diverse stakeholders and senior thought leaders from across the biomedical enterprise, this event engaged participants in discussion on the health of biomedical innovation in the United States, obstacles to innovation, policy options for overcoming those obstacles, and key metrics that can be used to evaluate whether the U.S. biomedical enterprise is effectively delivering new and innovative medical products to the patients who need them. More information and event materials at: http://goo.gl/fJ91H
Length: 01:32

Contact

Questions about Unchanged Fiscal Policies Will Hollow Out Investments Made in Bioscience

Want more info about Unchanged Fiscal Policies Will Hollow Out Investments Made in Bioscience? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question